Is ResMed Inc. overvalued?

ResMed Inc. (RMD) looks undervalued — trading about 11% below its fair value.

Undervalued

Price

$239.53

Fair value

$266.28

Current P/E

25.2

Normal P/E

28.0

Market cap

$33.69B

Dividend yield

1.1%

Return on equity

25.1%

Sector

Healthcare

Fair value compares RMD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks